Literature DB >> 20047583

Role of inflammatory cytokines and eNOS gene polymorphism in pathophysiology of pre-eclampsia.

Archana Singh1, Deepika Sharma, Chitra Raghunandan, Jayashree Bhattacharjee.   

Abstract

PROBLEM: Pre-eclampsia involves endothelial vascular dysfunction. The aim of this study was to test the hypothesis that (i) endothelial nitric oxide (NO) synthase Glu298Asp gene polymorphism limits constitutive NO production causing endothelial dysfunction and (ii) inflammatory cytokines impairs endothelium dependent relaxation in pre-eclampsia. METHOD OF STUDY: This cross-sectional study included 50 women with pre-eclampsia and 50 healthy pregnant women. Their blood samples were analyzed for NO, inflammatory cytokines and endothelial NO synthase (eNOS) gene polymorphism. RESULT: Decreased NO levels whereas increased tumor necrosis factor-alpha, interleukin (IL)-6 and interleukin-2 were found in pre-eclampsia (P < 0.001). No significant differences were found in genotype/allele distribution between two groups. Significant negative correlation was observed between NO and IL-6 in pre-eclamptic group (P = 0.001).
CONCLUSION: An IL-6-mediated endothelium dependent NO-cyclic guanine monophosphate-mediated relaxation pathway may be inhibited in systemic vessels in pre-eclampsia. As observed in this study Glu298Asp eNOS gene polymorphism did not showed significant association with pre-eclampsia.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 20047583     DOI: 10.1111/j.1600-0897.2009.00781.x

Source DB:  PubMed          Journal:  Am J Reprod Immunol        ISSN: 1046-7408            Impact factor:   3.886


  8 in total

Review 1.  Candidate Gene, Genome-Wide Association and Bioinformatic Studies in Pre-eclampsia: a Review.

Authors:  Semone Thakoordeen; Jagidesa Moodley; Thajasvarie Naicker
Journal:  Curr Hypertens Rep       Date:  2018-08-29       Impact factor: 5.369

2.  Microbial invasion of the amniotic cavity in preeclampsia as assessed by cultivation and sequence-based methods.

Authors:  Daniel B DiGiulio; Mariateresa Gervasi; Roberto Romero; Shali Mazaki-Tovi; Edi Vaisbuch; Juan Pedro Kusanovic; Kimberley S Seok; Ricardo Gómez; Pooja Mittal; Francesca Gotsch; Tinnakorn Chaiworapongsa; Enrique Oyarzún; Chong Jai Kim; David A Relman
Journal:  J Perinat Med       Date:  2010-09       Impact factor: 1.901

3.  Nitric oxide generation affects pro- and anti-angiogenic growth factor expression in primary human trophoblast.

Authors:  K A Groesch; R J Torry; A C Wilber; R Abrams; A Bieniarz; L J Guilbert; D S Torry
Journal:  Placenta       Date:  2011-09-29       Impact factor: 3.481

4.  Interleukin-6 and its correlations with maternal characteristics and echocardiographic parameters in pre-eclampsia, gestational hypertension and normotensive pregnancy.

Authors:  Dolina Gencheva; Fedya Nikolov; Ekaterina Uchikova; Rosen Mihaylov; Blagovesta Pencheva; Maria Vasileva
Journal:  Cardiovasc J Afr       Date:  2021-09-20       Impact factor: 0.802

5.  The relationship of hypovitaminosis D and IL-6 in preeclampsia.

Authors:  Lai Xu; Minjae Lee; Arun Jeyabalan; James M Roberts
Journal:  Am J Obstet Gynecol       Date:  2013-09-29       Impact factor: 8.661

6.  Deletion of GIT1 Impacts eNOS Activity To Aggravate sFlt-1-Induced Preeclampsia Phenotype in Mice.

Authors:  Shenghong Zhang; Cuili Zou; Qiaoqin Zhang
Journal:  G3 (Bethesda)       Date:  2018-10-03       Impact factor: 3.154

7.  Placental endothelial nitric oxide synthase expression and role of oxidative stress in susceptibility to preeclampsia in Pakistani women.

Authors:  Ghazala Shaheen; Sarwat Jahan; Qurat Ul Ain; Asad Ullah; Tayyaba Afsar; Ali Almajwal; Iftikhar Alam; Suhail Razak
Journal:  Mol Genet Genomic Med       Date:  2019-11-08       Impact factor: 2.183

8.  Association of endothelial nitric oxide synthase gene variants with preeclampsia.

Authors:  Ghazala Shaheen; Sarwat Jahan; Nousheen Bibi; Asmat Ullah; Rani Faryal; Ali Almajwal; Tayyaba Afsar; Dara Al-Disi; Mahmoud Abulmeaty; Abdulaziz Abdullah Al Khuraif; Mohammed Arshad; Suhail Razak
Journal:  Reprod Health       Date:  2021-07-28       Impact factor: 3.223

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.